Thank You!
Thank you for your email subscription. Check your email to get Coupon Code.
Blue Ocean Strategy of Wyeth Pharmaceuticals in 2009 Transformation at the Site Level
Posted by Matthew Harvey on Mar-29-2023
Introduction
The blue ocean strategy refers to a situation or a market where there is no irrelevant competition, or where there is negligible competition. The blue ocean strategy of Wyeth Pharmaceuticals in 2009 Transformation at the Site Level is focused on searching for new markets and business avenues which operate with minimal pricing pressures. The blue ocean strategy can be applied across different sectors and industries, and the businesses that exist within them. Wyeth Pharmaceuticals in 2009 Transformation at the Site Level blue ocean strategy is pivoted on entering new market spaces, or developing them as well as on innovation focused internally or externally that helps reinvent the industry to ensure no irrelevant competition (Kim & Mauborgne, 2014).
Moving away from saturated markets
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level continues to operate in saturated market spaces, and is restricted in growth and expansion. The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level’s businesses often face hurdles in the way of development and are also faced with increasingly intense pricing pressures- and are thus said to operate in a red ocean. A red ocean is marked with cut-throat competition and pricing wars that compromise the profits for all players. Pressures in saturated markets along with narrow growth spaces had forced the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level to search for new avenues – vertically or horizontally – to be able to enjoy higher market shares, and swim in blue oceans (Kim & Mauborgne, 2014).
Blue ocean strategy and differentiation
New industry boundaries
As companies and organizations move towards blue oceans, they redraw and redesign industry boundaries. This is possible through innovation and creativity. The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level also explores new platforms and channels, as well as means of doing business and is thus able to expand existing industry boundaries. The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has also been able to show the potential of developing new industries through its innovations – by identifying new spaces and making the competition irrelevant (Agnihotri, 2016).
Differentiation
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has focused on differentiation under the blue ocean strategy. The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level’s efforts towards differentiation are focused on creating unique value for the customers in its product and service offerings (Agnihotri, 2016; Blue Ocean Strategy, 2022).
Cost efficiencies and low cost
Under blue oceans, the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level also focuses on maintaining affordability for the value additions and differentiated products and services that it offers. The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level commonly continuously reevaluates and reassesses its own processes and systems to maintain high-cost efficiencies (Freedman, 2022).
Value innovation – value addition and low-cost maintenance
In doing so, the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has been able to explore blue oceans through value additions as well as affordability for consumers. The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has been able to successfully identify what consumer’s value and include it in its offerings and value propositions. At the same time, the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has been able to provide the value differentiation at affordable costs. In this manner, the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level enjoys high levels of value innovation (Kim, 2002; Kim & Mauborgne, 2014).
Understanding red oceans
Under red oceans, where the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level previously operated, all layers had accepted the predefined structures and boundaries of the industry, and had continued to operate as well as compete within these (The Economic Times, 2022).
Cut throat competition
To be able to remain profitable and successful, players, including the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level within red oceans, focused efforts on developing and maintaining competitive advantages over one another, and other players. This advantage was largely cost-based, as in the case of the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level. In this way, wealth was only redistributed at the expense of other players, and the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level failed to create any new wealth in the red oceans (Kim & Mauborgne, 2005).
Understanding blue oceans
Under the blue ocean strategy, the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level operates in an industry and market space that is not marked with set boundaries or structures. These blue ocean structures have been recreated by the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level at large, as well as by other players. Other players have also contributed to the restructuring of the industry through innovation (Kim & Mauborgne, 2014).
Restructuring industrial boundaries under the blue ocean strategy
Under the blue ocean strategy, the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level is not restricted by predefined rules, barriers, and principles. Instead, the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has been able to shift its strategic direction and attention from focusing on supply towards working on developing and creating demand (Blue Ocean Strategy, 2022). The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level, in this manner, is focused on the building of value innovation in its offerings, along with ensuring efforts towards building and maintaining differentiation and cost-effectiveness. In this way, the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has been able to immaterialize the competition (Kim & Mauborgne, 2017).
Strategic directions for blue oceans
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has four different strategic directions, which it can choose from four continuing to pursue its blue ocean strategy. All of these strategic directions will strengthen the company’s current business position and will supports its strategy of value addition and cost efficiencies, as well as differentiation – allowing it to develop strong and sustainable market positions. These directions are
Raise
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level should assess and evaluate the current industry standards and practices.
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level should identify loopholes, and areas which can be improved, expanded upon, or developed a new within the industry.
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level should identify different drivers and factors within the industry boundaries.
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level should identify through research and observation the different factors that could raise above the existing industry standards (Kim, 2002; Kim & Mauborgne, 2017).
Eliminate
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level should assess and observe current industry standards.
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level should observe players’ practices within the industry, and relate the same with the industry standards.
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level can identify the standards which are not needed, which are obsolete, and which may slow down operations and processes.
-
These standards can be eliminated in own operations by the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level (Kim & Mauborgne, 2014; Freedman, 2022).
Reduce
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level can also assess an observe industry standards for identifying factors that are not needed, or needed partially.
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level can work on reducing these standards to enhance operational performance and maximum utilization of resources as well as value addition (The Economic Times, 2022; Kim & Mauborgne, 2014).
Created
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level can also expand current industry boundaries and standards.
-
This expansion will be possible by the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level through expanding and creating new standards.
-
The new standards can be created by the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level through observing industry processes and operations, and identifying potential loopholes.
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level can introduce new processes and standards to redesign industry boundaries (Agnihotri, 2016; Kim & Mauborgne, 2005).
Blue ocean strategy: organizational competencies
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has been able to successfully implement the blue ocean strategy because of three important organizational elements (Freedman, 2022). These organizational elements have allowed the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level to explore blue oceans, experiment successfully with innovation, and add value to its product offerings. These elements include the following:
Mindset
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has a progressive mindset that is rooted in this participative and visionary leadership (Bratton, 2020).
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has a positive and can-do attitude and mindset.
-
This mindset has allowed the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level to achieve success through high focus and efforts (Wilson, 2018).
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has high motivation levels of employees – which enhances the optimal performance of the organization and has allowed it to explore Blue Ocean through creativity (Kim & Mauborgne, 2017; Kim & Mauborgne, 2005; Wilson, 2018).
Tools
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has access to multiple resources that has allowed it to take advantage of the blue ocean strategy (Mebert & Lowe, 2017).
-
These resources Wyeth Pharmaceuticals in 2009 Transformation at the Site Level capabilities are internal as well as external for the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level.
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has also invested resources and trainings for developing internal capabilities and capacities for ensuring upgraded skills and increased value addition (Buchanan & Huczynski, 2019; Chernev, 2018).
Culture
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has a learning culture, and encourages all employees to ask questions and carry out healthy discussions (Anthony, 2021; Schein, 2010).
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has a culture that is focused on research and development, which in turn leads to new innovations and solutions for existing demands and challenges (Wunder, 2019).
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has an inclusive and diverse culture, which leads to increased synergies that allow the development and implementation of blue ocean strategies easily (Wilson, 2018).
Using the blue ocean strategy effectively: steps for successful implementation
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has developed the blue ocean strategy following systematic and organized processes and steps (Kim & Mauborgne, 2017). The steps that the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level undertook for developing the blue ocean strategy include:
Step1
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level conducted thorough market and industry research to identify the right place to work towards developing a core team (Kim & Mauborgne, 2014; Freedman, 2022). This core team was responsible for driving Wyeth Pharmaceuticals in 2009 Transformation at the Site Level forward strategically towards new value additions and differentiations (Blue Ocean Strategy, 2022; Kim & Mauborgne, 2017 b).
Step2
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level continued to conduct deep market analysis as well as studied and assessed the competition closely. This was needed by the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level to identify potential opportunities, and demand gaps in the existing industry as well as potential structural changes in the existing industrial boundaries (Blue Ocean Strategy, 2022).
Step3
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level’s assessment of the macro environment, and the market spaces allowed it to also identify the challenges and issues hidden in the current industry structure and design (Machado, 2019; Kim & Mauborgne, 2017 b). These issues and problems have restricted the industry size, and led to restrictive growth for the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level. The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level was also blue to identify new non-customers in this assessment- which could be turned into future consumers (Blue Ocean Strategy, 2022).
Step4
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level worked to redesign and reconstruct the industry boundaries and structures in a systematic manner. This was done through identifying new opportunities, as well as through exploring new innovations and valuations in existing offerings (Blue Ocean Strategy, 2022).
Step5
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level finally elected the right blue ocean move, i.e. conducted various pilot testing’s and market testing for its new offerings before finalizing and launching them in the market to attract new consumers, and explore new markets (Blue Ocean Strategy, 2022).
Tackling challenges on the way to Blue Ocean
Restructuring and reorganizing the boundaries and structures of the industries is not that simple (Anthony, 2021; Kim & Mauborgne, 2017 b). Managers and practitioners of the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level seek to renew the value of their offerings within the organization – mostly using new technologies and advances networks to not only create value propositions, but also transform existing ones (Kim & Mauborgne, 2005; Kim, 2002). However, the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has been able to overcome resistance towards change and innovation within the organization, as well as in the external environments, because of:
Organizational culture
The culture within the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level supports exploration and innovation. This culture is important for supporting the development and implementation of new ideas that boost the value propositions of the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level (Chernev, 2018; Bratton, 2020; Martinez, Beaulieu, & Gibbons, 2015).
Business design
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level also continually practices business design (Freedman, 2022). The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level ensures that it’s leading from the font. This means that the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level ensures that its teams are empowered, and confident in tackling ambiguous and difficult challenges and issues. This allows the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level to identify new opportunities and innovate (Wunder, 2019).
Strong and visionary leadership
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has a forward-thinking, progressive, charismatic leadership. This leadership ensures that the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level continually engages in disruptive processes and innovations – which in turn allow the company to explore and implement the blue ocean strategy. The leadership is supportive of, and facilitates the change processes within the company (Machado, 2019).
Communication
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level ensures that all communication within the organization is transparent and quick (Chernev, 2018; Buchanan & Huczynski, 2019). The leadership and management levels have frequent meetings within the company along managerial levels (Wilson, 2018; Wunder, 2019). This allows employees to feel on board of the happenings, and be part of a change from the beginning – understanding its need and facilitating its implementation. This is critical for ensuring successful innovation and adoption of the blue ocean strategy (Anthony, 2021; Chernev, 2018; Kim, 2002).
Value innovation in blue ocean strategy
Value innovation within the blue ocean strategy focuses on value as well as innovation (Blue Ocean Strategy, 2022; Kim & Mauborgne, 2017). This means that the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level seeks to innovate and create value at the same time as a means of differentiation within the marketplace to be able to implement the blue ocean strategy (Kim & Mauborgne, 2014). The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level does not only engage in value creation – which focuses on scaling the existing value only instead of creating a new one (Blue Ocean Strategy, 2022; Agnihotri, 2016; Kim & Mauborgne, 2014).
Technology innovation
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level engages in value innovation through technology innovation. The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level ensures that it uses advanced and progressive technology to address various consumer demands and problems as well as needs in innovative ways and manners (Kim & Mauborgne, 2005). However, the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level ensures that it focuses on value innovation rather than technology innovation in its value propositions so that new value through technology is created for consumers (Kim, 2002; Wilson, 2018).
Low cost
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level also ensures affordability with value innovation. The value innovation allows the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level to operate at low costs, and maintain cost efficiencies (Chernev, 2018). As a result, the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level maintains low costs and high value for consumers – allowing it to tap into new consumer groups as well. As a result, the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level is able to enjoy a high growth rate as well as increased sales and profits (Kim & Mauborgne, 2014).
The strategies and strategic directions for designing and implementing the blue ocean strategy have been overseen through some guiding and fundamental principles by the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level. These include”
Formulation principles
Redesigning the industry
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level sought to reconstruct, redesign and rebuild the market boundaries and standards.
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level was bold enough to redefine the industry space and the market space in which it operated (Mebert & Lowe, 2017).
Long term focus
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level focused on long-term success and sustainability, instead of short-term gains and numbers.
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level was visionary, and aw beyond the existent customer demand and needs (Freedman, 2022).
Demand creation
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level creates demand for the new value-added offerings it manufactured and proposed in the blue oceans (Kim, 2002).
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level tapped into new customer groups and target audiences (Kim & Mauborgne, Red Ocean Traps (Harvard Business Review Classics), 2017 b).
Execution principles
Overcoming organizational challenges
Organizational culture
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has a result organizational culture (Martinez, Beaulieu, & Gibbons, 2015; Schein, 2010).
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level invests in research and development.
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level is quick to adapt to change and has a disciplined change management team to oversee change processes (Chernev, 2018; Kim & Mauborgne, 2014).
Environmental assessment
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level continually assesses its internal and external environments and creates contingency plans (Chernev, 2018; Machado, 2019).
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level engages in pre-strategic planning to help strengthen its strategic focus and direction (Wilson, 2018; Kim & Mauborgne, 2017 b).
Leadership
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has a visionary leadership (Bratton, 2020).
-
The leadership at the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has a participative approach which encourages employee motivation and their organizational commitment.
-
The leadership ensures optimal organizational performance at the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level (Freedman, 2022; Kim & Mauborgne, 2005).
Developing execution strategy
-
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has developed a sequential strategic direction for execution.
-
The execution of the blue ocean strategy is based on market research (Anthony, 2021).
-
The execution of the blue ocean strategy has been carefully planned to ensure that it’s timely.
-
The execution involves all parts and members of the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level (The Economic Times, 2022; Kim, 2002).
Blue ocean strategic Tools
The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has been able to use multiple operational and strategic tools.
Shift in organizational mindset
These tools kits have been important for the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level in helping it develop the right mindset needed for aligning processes and systems towards the blue ocean strategic direction (Kim & Mauborgne, 2017 b). The tools have been a powerful source for the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level in facilitating it towards aligning its resources, and identifying potential blue oceans (Kim, 2002). The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has been diligent in ensuring that its teams and organizational members are familiar with the blue can strategies and tools so that the shift in their mindset is facilitated and strengthened (Wunder, 2019).
Cultural driver
Moreover, the tools also ensure increased alignment of the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level’s culture with the strategy. This, in turn, has allowed the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level to realize the increased number of opportunities, and embed creativity in its internal processes and systems (Kim, 2002; Buchanan & Huczynski, 2019).
These tools include, for example:
-
Value innovation
-
Six path framework
-
Strategy canvas
-
Four action framework
-
Tipping point leadership
-
ERRC Grid
-
Pioneer settler migrator map
-
Buyer utility map
-
3 tiers of non-customers
-
Fair processes
-
Visualizing strategy (The Economic Times, 2022)
Conclusion
With the use of the blue ocean strategy, the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has been able to redesign the industrial boundaries and standards using multiple techniques and tools that have been identified and discussed briefly in this paper.
The blue ocean strategy has been an important strategic element for the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level. The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has been able to explore new markets and tap into new customer groups through using the blue ocean strategy. This has been possible for the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level through continuous investment in research and development as well as through its organizational cultural, which is focused on innovation and creativity. The Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has been able to make use of innovative processes and progressive technology to create value innovation. At the same time, the Wyeth Pharmaceuticals in 2009 Transformation at the Site Level has moved out of red oceans and no longer competes over pricing strategies. This has also allowed Wyeth Pharmaceuticals in 2009 Transformation at the Site Level to build a cost advantage, and maintain affordability in its offerings for customers.
References
Agnihotri, A. (2016). Extending boundaries of blue ocean strategy. Journal of Strategic Marketing, 24 (6), 519-528.
Anthony, H. (2021). Understanding strategic management. New York: Oxford University Press.
Blue Ocean Strategy. (2022). WHAT IS BLUE OCEAN STRATEGY? Retrieved 2022, from Blue Ocean Strategy: https://www.blueoceanstrategy.com/what-is-blue-ocean-strategy/
Bratton, J. (2020). Organizational leadership. Newcastle upon Tyne: Sage.
Buchanan, D., & Huczynski, A. (2019). Organizational behaviour. London: Pearson UK.
Chernev, A. (2018). Strategic marketing management. Berlin/Heidelberg: Cerebellum Press.
Freedman, M. (2022). Blue Ocean Strategy: Creating Your Own Market . Retrieved 2022, from https://www.businessnewsdaily.com/5647-blue-ocean-strategy.html
Kim, W. (2002). Blue ocean strategy: from theory to practice. California management review, 47 (3), 105-121.
Kim, W., & Mauborgne, R. (2005). Value innovation: a leap into the blue ocean. Journal of business strategy .
Kim, W., & Mauborgne, R. (2014). Blue ocean strategy, expanded edition: How to create uncontested market space and make the competition irrelevant. Boston, Massachusetts: Harvard business review Press.
Kim, W., & Mauborgne, R. (2017 b). Red Ocean Traps (Harvard Business Review Classics). Boston, Massachusetts: Harvard Business Review Press.
Kim, W., & Mauborgne, R. (2017). Blue ocean leadership (Harvard business review classics). Boston, Massachusetts, United States: Harvard Business Review Press.
Machado, C. (2019). Organizational Behaviour and Human Resource Management. Berlin: Springer.
Martinez, E., Beaulieu, N., & Gibbons, R. (2015). Organizational culture and performance. American economic review, 105 (5), 331-35.
Mebert, A., & Lowe, S. (2017). Blue Ocean Strategy. Literary Criticism.
Schein, E. (2010). Organizational culture and leadership. Hoboken, New Jersey: John Wiley & Sons.
The Economic Times. (2022). What is 'Blue Ocean Strategy' . Retrieved 2022, from https://economictimes.indiatimes.com/definition/blue-ocean-strategy
Wilson, F. (2018). Organizational behaviour and work: a critical introduction. New York: Oxford university press.
Wunder, T. (2019). Rethinking strategic management: Sustainable strategizing for positive impact. Berlin: Springer Nature.
Related Article
- PESTEL Analysis of Wyeth Pharmaceuticals in 2009 Transformation at the Site Level
- Hofstede Cultural Model of Wyeth Pharmaceuticals in 2009 Transformation at the Site Level
- Net Present Value (NPV) Analysis of Wyeth Pharmaceuticals in 2009 Transformation at the Site Level
- Marketing Mix (4Ps) Analysis of Wyeth Pharmaceuticals in 2009 Transformation at the Site Level
- Corporate Social Responsibility of Wyeth Pharmaceuticals in 2009 Transformation at the Site Level
- Wyeth Pharmaceuticals in 2009 Transformation at the Site Level Discounted Cash Flow (DCF) Analysis
- VRIO Analysis of Wyeth Pharmaceuticals in 2009 Transformation at the Site Level
- Wyeth Pharmaceuticals in 2009 Transformation at the Site Level Case Solution
- Marketing Strategy for Wyeth Pharmaceuticals in 2009 Transformation at the Site Level
Latest Feedback
Sheng Hi
Verified
My first priority was communication with writer and this service provided me an error-free process of conversation with writer. I got the paper that was completed on time and with suitable charges.
Romane Tony
Verified
So happy with the assignment that I received. Wish I found you guys sooner. Anyway, Thanks a lot!
Madison George
Verified
I hired another service for a research paper. It provided me with excellent data but it did not use the well-marked primary resources. I looked at many services but trusted this service; I do not know why. I am grateful for utilizing the authentic references because it is what my teacher likes.
Jesca Suhail
Verified
I don’t like to spend all my time taking assignments to write, so I like to pay a call to this service to be freed from the papers.
Clement Aksel
Verified
These guys did an outstanding job for editing my paper and I obtained an A+. Thank you very much!
Marco Kevin
Verified
This custom writing service is honestly great and I contained what I was looking for. The prices were very cheap and I’m a happy customer of this service. I’m grateful!
Calculate the Price of Your Order
Next Article
- Antegren: A Beacon of Hope (D) Blue Ocean Strategy
- Sms For Life (A): A Public-Private Collaboration To Prevent Stock-Outs Of Life Saving Marlaria Drugs In Africa Blue Ocean Strategy
- Hans Fritz at Novartis Thailand (B): The First Six Months Blue Ocean Strategy
- Rx Depot: Importing Drugs from Canada Blue Ocean Strategy
- Jan Eriksson at Novartis Indonesia (B) Blue Ocean Strategy
- Sms For Life (C): Sustaining The Initiative And Leveraging Its Social And Business Value For Novartis Blue Ocean Strategy
- GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (D): US DEVELOPMENTS Blue Ocean Strategy
- Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) Blue Ocean Strategy
- The Flaxil Label (C): Debrief and Endnotes Blue Ocean Strategy
- Shar Matin (A) Blue Ocean Strategy
Previuos Article
- Making the Case Blue Ocean Strategy
- Joe Smith's Closing Analysis (B) Blue Ocean Strategy
- Joe Smith's Closing Analysis (A), Spanish Version Blue Ocean Strategy
- GMAC: The Pipeline Blue Ocean Strategy
- On Writing Teaching Notes Well Blue Ocean Strategy
- Exxon Corp.: Trouble at Valdez Blue Ocean Strategy
- Ashland Oil, Inc.: Trouble at Floreffe (A) Blue Ocean Strategy
- Ashland Oil, Inc.: Trouble at Floreffe (B) Blue Ocean Strategy
- Ashland Oil, Inc.: Trouble at Floreffe (C) Blue Ocean Strategy
- Ashland Oil, Inc.: Trouble at Floreffe (D) Blue Ocean Strategy
Be a great writer or hire a greater one!
Academic writing has no room for errors and mistakes. If you have BIG dreams to score BIG, think out of the box and hire EssayPandas with BIG enough reputation.
Our Guarantees
- Quality assured
- Proof of no plagiarism
- Qualified writers
- Data security
- 24/7 support
- On time delivery
Interesting Fact
Most recent surveys suggest that around 76 % students try professional academic writing services at least once in their lifetime!
Order Now